200 related articles for article (PubMed ID: 18463999)
1. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.
Leventhal AM; Kahler CW; Ray LA; Stone K; Young D; Chelminski I; Zimmerman M
Am J Addict; 2008; 17(3):218-23. PubMed ID: 18463999
[TBL] [Abstract][Full Text] [Related]
2. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
Camacho A; Akiskal HS
J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
[TBL] [Abstract][Full Text] [Related]
3. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants.
Mahoney JJ; Kalechstein AD; De La Garza R; Newton TF
Am J Addict; 2008; 17(2):83-98. PubMed ID: 18393050
[TBL] [Abstract][Full Text] [Related]
4. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.
Ciccarone D
Prim Care; 2011 Mar; 38(1):41-58. PubMed ID: 21356420
[TBL] [Abstract][Full Text] [Related]
5. The Stimulant Selective Severity Assessment: A replication and exploratory extension of the Cocaine Selective Severity Assessment.
Walker R; Northrup TF; Tillitski J; Bernstein I; Greer TL; Trivedi MH
Subst Use Misuse; 2019; 54(3):351-361. PubMed ID: 30657406
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
[TBL] [Abstract][Full Text] [Related]
7. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.
Hatch-Maillette M; Wells EA; Doyle SR; Brigham GS; Daley D; DiCenzo J; Donovan D; Garrett S; Horigian VE; Jenkins L; Killeen T; Owens M; Perl HI
J Subst Abuse Treat; 2016 Sep; 68():74-82. PubMed ID: 27431050
[TBL] [Abstract][Full Text] [Related]
8. Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
Chawarski MC; Hawk K; Edelman EJ; O'Connor P; Owens P; Martel S; Coupet E; Whiteside L; Tsui JI; Rothman R; Cowan E; Richardson L; Lyons MS; Fiellin DA; D'Onofrio G
Ann Emerg Med; 2020 Dec; 76(6):782-787. PubMed ID: 32782084
[TBL] [Abstract][Full Text] [Related]
9. Response: anticipating new medications.
Bogenschutz MP; DeMarzo LJ; Roll J
Addict Sci Clin Pract; 2008 Jun; 4(2):36-8. PubMed ID: 18497716
[No Abstract] [Full Text] [Related]
10. Use of stimulants to treat cocaine and methamphetamine abuse.
Moeller FG; Schmitz JM; Herin D; Kjome KL
Curr Psychiatry Rep; 2008 Oct; 10(5):385-91. PubMed ID: 18803911
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results.
Stitzer ML; Petry N; Peirce J; Kirby K; Killeen T; Roll J; Hamilton J; Stabile PQ; Sterling R; Brown C; Kolodner K; Li R
J Consult Clin Psychol; 2007 Oct; 75(5):805-11. PubMed ID: 17907862
[TBL] [Abstract][Full Text] [Related]
13. Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia.
Batki SL; Harris DS
Am J Addict; 2004; 13(5):461-70. PubMed ID: 15764424
[TBL] [Abstract][Full Text] [Related]
14. The search for medications to treat stimulant dependence.
Kampman KM
Addict Sci Clin Pract; 2008 Jun; 4(2):28-35. PubMed ID: 18497715
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
[TBL] [Abstract][Full Text] [Related]
16. Impulsivity is associated with treatment non-completion in cocaine- and methamphetamine-dependent patients but differs in nature as a function of stimulant-dependence diagnosis.
Winhusen T; Lewis D; Adinoff B; Brigham G; Kropp F; Donovan DM; Seamans CL; Hodgkins CC; Dicenzo JC; Botero CL; Jones DR; Somoza E
J Subst Abuse Treat; 2013; 44(5):541-7. PubMed ID: 23305820
[TBL] [Abstract][Full Text] [Related]
17. Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up.
Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
Am J Addict; 2008; 17(2):99-102. PubMed ID: 18393051
[TBL] [Abstract][Full Text] [Related]
18. Anhedonia associated with stimulant use and dependence in a population-based sample of American adults.
Leventhal AM; Brightman M; Ameringer KJ; Greenberg J; Mickens L; Ray LA; Sun P; Sussman S
Exp Clin Psychopharmacol; 2010 Dec; 18(6):562-9. PubMed ID: 21186931
[TBL] [Abstract][Full Text] [Related]
19. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine abstinence syndrome: preliminary findings.
Newton TF; Kalechstein AD; Duran S; Vansluis N; Ling W
Am J Addict; 2004; 13(3):248-55. PubMed ID: 15370944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
